Imperial College London

PROFESSOR AZEEM MAJEED

Faculty of MedicineSchool of Public Health

Chair - Primary Care and Public Health & Head of Department
 
 
 
//

Contact

 

+44 (0)20 7594 3368a.majeed Website

 
 
//

Assistant

 

Ms Dorothea Cockerell +44 (0)20 7594 3368

 
//

Location

 

Reynolds BuildingCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Fitzmaurice:2019:10.1001/jamaoncol.2019.2996,
author = {Fitzmaurice, C and Abate, D and Abbasi, N and Abbastabar, H and Abd-Allah, F and Abdel-Rahman, O and Abdelalim, A and Abdoli, A and Abdollahpour, I and Abdulle, ASM and Abebe, ND and Abraha, HN and Abu-Raddad, LJ and Abualhasan, A and Adedeji, IA and Advani, SM and Afarideh, M and Afshari, M and Aghaali, M and Agius, D and Agrawal, S and Ahmadi, A and Ahmadian, E and Ahmadpour, E and Ahmed, MB and Akbari, ME and Akinyemiju, T and Al-Aly, Z and AlAbdulKader, AM and Alahdab, F and Alam, T and Alamene, GM and Alemnew, BTT and Alene, KA and Alinia, C and Alipour, V and Aljunid, SM and Bakeshei, FA and Almadi, MAH and Almasi-Hashiani, A and Alsharif, U and Alsowaidi, S and Alvis-Guzman, N and Amini, E and Amini, S and Amoako, YA and Anbari, Z and Anber, NH and Andrei, CL and Anjomshoa, M and Ansari, F and Ansariadi, A and Appiah, SCY and Arab-Zozani, M and Arabloo, J and Arefi, Z and Aremu, O and Areri, HA and Artaman, A and Asayesh, H and Asfaw, ET and Ashagre, AF and Assadi, R and Ataeini},
doi = {10.1001/jamaoncol.2019.2996},
journal = {JAMA Oncology},
pages = {1749--1768},
title = {Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017},
url = {http://dx.doi.org/10.1001/jamaoncol.2019.2996},
volume = {5},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Importance Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting, and budgeting have been identified as major obstacles in achieving these goals. All of these have in common that they require information on the local cancer epidemiology. The Global Burden of Disease (GBD) study is uniquely poised to provide these crucial data.Objective To describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning.Evidence Review We used the GBD study estimation methods to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs). Results are presented at the national level as well as by Socio-demographic Index (SDI), a composite indicator of income, educational attainment, and total fertility rate. We also analyzed the influence of the epidemiological vs the demographic transition on cancer incidence.Findings In 2017, there were 24.5 million incident cancer cases worldwide (16.8 million without nonmelanoma skin cancer [NMSC]) and 9.6 million cancer deaths. The majority of cancer DALYs came from years of life lost (97%), and only 3% came from years lived with disability. The odds of developing cancer were the lowest in the low SDI quintile (1 in 7) and the highest in the high SDI quintile (1 in 2) for both sexes. In 2017, the most common incident cancers in men were NMSC (4.3 million incident cases); tracheal, bronchus, and lung (TBL) cancer (1.5 million incident cases); and prostate cancer (1.3 million incident cases). The most common causes of cancer deaths and DALYs for m
AU - Fitzmaurice,C
AU - Abate,D
AU - Abbasi,N
AU - Abbastabar,H
AU - Abd-Allah,F
AU - Abdel-Rahman,O
AU - Abdelalim,A
AU - Abdoli,A
AU - Abdollahpour,I
AU - Abdulle,ASM
AU - Abebe,ND
AU - Abraha,HN
AU - Abu-Raddad,LJ
AU - Abualhasan,A
AU - Adedeji,IA
AU - Advani,SM
AU - Afarideh,M
AU - Afshari,M
AU - Aghaali,M
AU - Agius,D
AU - Agrawal,S
AU - Ahmadi,A
AU - Ahmadian,E
AU - Ahmadpour,E
AU - Ahmed,MB
AU - Akbari,ME
AU - Akinyemiju,T
AU - Al-Aly,Z
AU - AlAbdulKader,AM
AU - Alahdab,F
AU - Alam,T
AU - Alamene,GM
AU - Alemnew,BTT
AU - Alene,KA
AU - Alinia,C
AU - Alipour,V
AU - Aljunid,SM
AU - Bakeshei,FA
AU - Almadi,MAH
AU - Almasi-Hashiani,A
AU - Alsharif,U
AU - Alsowaidi,S
AU - Alvis-Guzman,N
AU - Amini,E
AU - Amini,S
AU - Amoako,YA
AU - Anbari,Z
AU - Anber,NH
AU - Andrei,CL
AU - Anjomshoa,M
AU - Ansari,F
AU - Ansariadi,A
AU - Appiah,SCY
AU - Arab-Zozani,M
AU - Arabloo,J
AU - Arefi,Z
AU - Aremu,O
AU - Areri,HA
AU - Artaman,A
AU - Asayesh,H
AU - Asfaw,ET
AU - Ashagre,AF
AU - Assadi,R
AU - Ataeinia,B
AU - Atalay,HT
AU - Ataro,Z
AU - Atique,S
AU - Ausloos,M
AU - Avila-Burgos,L
AU - Avokpaho,EFGA
AU - Awasthi,A
AU - Awoke,N
AU - Ayala,Quintanilla BP
AU - Ayanore,MA
AU - Ayele,HT
AU - Babaee,E
AU - Bacha,U
AU - Badawi,A
AU - Bagherzadeh,M
AU - Bagli,E
AU - Balakrishnan,S
AU - Balouchi,A
AU - Bärnighausen,TW
AU - Battista,RJ
AU - Behzadifar,M
AU - Behzadifar,M
AU - Bekele,BB
AU - Belay,YB
AU - Belayneh,YM
AU - Berfield,KKS
AU - Berhane,A
AU - Bernabe,E
AU - Beuran,M
AU - Bhakta,N
AU - Bhattacharyya,K
AU - Biadgo,B
AU - Bijani,A
AU - Bin,Sayeed MS
AU - Birungi,C
AU - Bisignano,C
AU - Bitew,H
AU - Bjørge,T
AU - Bleyer,A
AU - Bogale,KA
AU - Bojia,HA
AU - Borzì,AM
AU - Bosetti,C
AU - Bou-Orm,IR
AU - Brenner,H
AU - Brewer,JD
AU - Briko,AN
AU - Briko,NI
AU - Bustamante-Teixeira,MT
AU - Butt,ZA
AU - Carreras,G
AU - Carrero,JJ
AU - Carvalho,F
AU - Castro,C
AU - Castro,F
AU - Catalá-López,F
AU - Cerin,E
AU - Chaiah,Y
AU - Chanie,WF
AU - Chattu,VK
AU - Chaturvedi,P
AU - Chauhan,NS
AU - Chehrazi,M
AU - Chiang,PP-C
AU - Chichiabellu,TY
AU - Chido-Amajuoyi,OG
AU - Chimed-Ochir,O
AU - Choi,J-YJ
AU - Christopher,DJ
AU - Chu,D-T
AU - Constantin,M-M
AU - Costa,VM
AU - Crocetti,E
AU - Crowe,CS
AU - Curado,MP
AU - Dahlawi,SMA
AU - Damiani,G
AU - Darwish,AH
AU - Daryani,A
AU - das,Neves J
AU - Demeke,FM
AU - Demis,AB
AU - Demissie,BW
AU - Demoz,GT
AU - Denova-Gutiérrez,E
AU - Derakhshani,A
AU - Deribe,KS
AU - Desai,R
AU - Desalegn,BB
AU - Desta,M
AU - Dey,S
AU - Dharmaratne,SD
AU - Dhimal,M
AU - Diaz,D
AU - Dinberu,MTT
AU - Djalalinia,S
AU - Doku,DT
AU - Drake,TM
AU - Dubey,M
AU - Dubljanin,E
AU - Duken,EE
AU - Ebrahimi,H
AU - Effiong,A
AU - Eftekhari,A E
DO - 10.1001/jamaoncol.2019.2996
EP - 1768
PY - 2019///
SN - 2374-2437
SP - 1749
TI - Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017
T2 - JAMA Oncology
UR - http://dx.doi.org/10.1001/jamaoncol.2019.2996
UR - https://jamanetwork.com/journals/jamaoncology/fullarticle/2752381
UR - http://hdl.handle.net/10044/1/73738
VL - 5
ER -